Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | CA5A | P35218 | 2/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.37 |
| ▸ | FDPS | P14324 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL211728 | 1.00 | SLC34A1 (0.58) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL29079484 | 1.00 | SLC34A1 (0.58) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL4401863 | 1.00 | SLC34A1 (0.58) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL236060 | 0.95 | SLC34A1 (0.54) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL3401942 | 0.95 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL8338313 | 0.95 | SLC34A1 (0.54) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL736577 | 0.95 | SLC34A1 (0.54) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL3400141 | 0.95 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL10379477 | 0.95 | SLC34A1 (0.54) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL141917 | 0.95 | SLC34A1 (0.54) | SLC34A1KDM4ECYP2C19KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 828 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117886842-A | Preparation method of trimethylsilanol | 浙江恒业成有机硅有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-113945532-B | Colorimetric detection method of triazolone | 昆明理工大学 | 2024-01-26 | — | — | CN | claimed |
| CN-117224482-A | Inhalation preparation for treating IPF diseases and preparation method thereof | 苏州易合医药有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-114231209-B | Quick-bonding water-based glue and preparation method thereof | 江苏奥斯佳材料科技股份有限公司 | 2023-09-26 | — | — | CN | claimed |
| CN-115120642-B | Method for simultaneously preparing rubusoside, total amino acid and polysaccharide from sweet tea | 湖南绿蔓生物科技股份有限公司 | 2023-08-22 | — | — | CN | claimed |
| CN-116515930-A | Method for preparing rhamnosyl icariside II by enzyme catalysis of total flavonoids of epimedium | 陕西理工大学 | 2023-08-01 | — | — | CN | claimed |
| CN-116508782-A | Novel slow-release chlorine dioxide disinfectant capable of reducing aerosol transmission risk of new coronaries in relatively closed environment | 北京三汀科技有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-116364926-A | Positive pole piece of sodium ion battery, preparation method of positive pole piece and sodium ion battery | 维科技术股份有限公司 | 2023-06-30 | — | — | CN | claimed |
| WO-2023087578-A1 | URAPIDIL HYDROCHLORIDE INJECTION AND PREPARATION METHOD THEREFOR | 石家庄四药有限公司 | 2023-05-25 | — | — | WO | claimed |
| CN-115998693-A | Preparation method of azithromycin freeze-dried product for injection | 苏州朗易生物医药研究有限公司 | 2023-04-25 | — | — | CN | claimed |
| EP-1085859-A1 | WOUND TREATMENT THROUGH INHIBITION OF ADENOSINE DIPHOSPHATE RIBOSYL TRANSFERASE | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2001-03-28 | — | — | EP | claimed |
| US-6187822-B1 | TO INHIBIT ADENOSINE DIPHOSPHATE-RIBOSYLATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR, WHEREIN THE ENZYME INHIBITOR IS SELECTED FROM VITAMIN K1, VITAMIN K3, NOVOBIOCIN, AND SILYBIN; HEALING WOUNDS SUCH AS DIAPER DERMATITIS | UNIVERSITY OF MEDICINE & DENTISTRY OF NJ | 2001-02-13 | — | — | US | claimed |
| WO-2000061092-A1 | ZINC CONTAINING DENTIFRICE COMPOSITIONS | WARNER-LAMBERT COMPANY (US) | 2000-10-19 | — | — | WO | claimed |
| WO-1999063982-A1 | WOUND TREATMENT THROUGH INHIBITION OF ADENOSINE DIPHOSPHATE RIBOSYL TRANSFERASE | UNIVERSITY OF MEDICINE & DENTISTRY OF NEW JERSEY (US) | 1999-12-16 | — | — | WO | claimed |
| WO-1997028805-A1 | THERAPEUTIC COMPOSITIONS CONTAINING A HEXAHYDRO-5-PYRIMIDINAMINE COMPOUND AND A MORPHOLINE-ETHER COMPOUND | WARNER-LAMBERT COMPANY (US) | 1997-08-14 | — | — | WO | claimed |
| US-5602183-A | DIAPER DERMATITIS; MIXTURE OF ANTIINFLAMMATORY AGENT ANDPYRUVATE COMPOUND, ANTIOXIDANT AND FATTY ACIDS | WARNER-LAMBERT COMPANY (US) | 1997-02-11 | — | — | US | claimed |
| WO-1996037227-A1 | DERMATOLOGICAL-WOUND HEALING COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME | WARNER-LAMBERT COMPANY (US) | 1996-11-28 | — | — | WO | claimed |
| EP-0512104-A1 | STABILIZED HEXAHYDRO-5-PYRIMIDINAMINE COMPOUNDS IN AQUEOUS SOLUTION AND METHODS FOR PREPARING SAME | WARNER-LAMBERT COMPANY (US) | 1992-11-11 | — | — | EP | claimed |
| WO-1992009283-A1 | STABILIZED HEXAHYDRO-5-PYRIMIDINAMINE COMPOUNDS IN AQUEOUS SOLUTION AND METHODS FOR PREPARING SAME | WARNER-LAMBERT COMPANY (US) | 1992-06-11 | — | — | WO | claimed |
| US-4115644-A | Process for preparing pure cefamandole from alkali metal and ammonium salts thereof | ELI LILLY AND COMPANY (US) | 1978-09-19 | — | — | US | claimed |